GlassScriptPhysician profile
Martin Eugene Turner
NPI 1811060361
$2,596.12
in general payments reported to CMS, 2019-2025
11 companies · $87.91 in 2025
The $87.91 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $62.82 · 2021: $252 · 2022: $394 · 2023: $1,252 · 2024: $348 · 2025: $87.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $837 · Food and Beverage: $764 · Education: $86.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $837.49 |
| Food and Beverage | $764.39 |
| Education | $86.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $852.72 | 2022-2024 | |
| Stryker Corporation | $425.26 | 2019-2025 | Triathlon, Aequalis Ascend Flex, Mako |
| Arthrex, INC. | $373.29 | 2023 | Shoulder Implants Fibertak Knotless |
| Ferring Pharmaceuticals INC. | $285.60 | 2019-2025 | Euflexxa |
| Anika Therapeutics, INC. | $201.17 | 2021 | |
| Depuy Synthes Sales INC. | $180.66 | 2019-2023 | Attune |
| Zimmer Biomet Holdings, INC. | $115.36 | 2020-2024 | Persona |
| Catalyst Orthoscience | $70.38 | 2024 | Catalyst Csr Shoulder System |
| Bioventus LLC | $35.18 | 2021-2022 | |
| Smith+Nephew, INC. | $33.40 | 2024 | Stravix |
| Solventum Corporation | $23.10 | 2024 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.